Cis-Acting Regulation of Brain-Specific ANK3 Gene Expression by a Genetic Variant Associated with Bipolar Disorder

Several genome-wide association studies for bipolar disorder (BD) have found a strong association of the Ankyrin 3 (ANK3) gene. This association spans numerous linked single-nucleotide polymorphisms (SNPs) in an ∼250-kb genomic region overlapping ANK3. The associated region encompasses predicted regulatory elements as well as two of the six validated alternative first exons, which encode distinct protein domains at the N-terminus of the protein also known as Ankyrin-G. Using RNA ligase-mediated rapid amplification of cDNA ends to identify novel transcripts in conjunction with a highly sensitive, exon-specific multiplexed mRNA expression assay, we detected differential regulation of distinct ANK3 transcription start sites and coupling of specific 5′ ends with 3′ mRNA splicing events in postmortem human brain and human stem cell-derived neural progenitors and neurons. Furthermore, allelic variation at the BD-associated SNP rs1938526 correlated with a significant difference in cerebellar expression of a brain-specific ANK3 transcript. These findings suggest a brain-specific cis-regulatory transcriptional effect of ANK3 that may be relevant to BD pathophysiology.

[1]  H. Gurling,et al.  Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non‐conservative amino acid change in a short isoform of ankyrin G , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[2]  Harunori Ohmori,et al.  Presynaptic activity regulates Na+ channel distribution at the axon initial segment , 2010, Nature.

[3]  Yousheng Shu,et al.  Short- and Long-Term Plasticity at the Axon Initial Segment , 2011, The Journal of Neuroscience.

[4]  M. Grubb,et al.  Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability , 2010, Nature.

[5]  V. Bennett,et al.  Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. , 2008, Trends in molecular medicine.

[6]  E. Vassos,et al.  The Cognitive Impact of the ANK3 Risk Variant for Bipolar Disorder: Initial Evidence of Selectivity to Signal Detection during Sustained Attention , 2011, PloS one.

[7]  B. Cooper,et al.  Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  N. Craddock,et al.  Genetics of bipolar disorder: successful start to a long journey. , 2009, Trends in genetics : TIG.

[9]  V. Bennett,et al.  Ankyrins and cellular targeting of diverse membrane proteins to physiological sites. , 2001, Current opinion in cell biology.

[10]  Catherine J. Stoodley,et al.  Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing , 2010, Cortex.

[11]  Jennifer L. Osborn,et al.  Direct multiplexed measurement of gene expression with color-coded probe pairs , 2008, Nature Biotechnology.

[12]  M. Gill,et al.  Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression. , 2010, Bipolar disorders.

[13]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[14]  R. Villanueva.  The cerebellum and neuropsychiatric disorders , 2012, Psychiatry Research.

[15]  Priscilla Wu,et al.  Ankyrin-Based Subcellular Gradient of Neurofascin, an Immunoglobulin Family Protein, Directs GABAergic Innervation at Purkinje Axon Initial Segment , 2004, Cell.

[16]  Working Group,et al.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ 4 Psychiatric GWAS Consortium Bipolar Disorder , 2012 .

[17]  H. Gurling,et al.  A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder , 2007, Pharmacogenetics and genomics.

[18]  Michael J. Ziller,et al.  Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.

[19]  Vann Bennett,et al.  A Common Ankyrin-G-Based Mechanism Retains KCNQ and NaV Channels at Electrically Active Domains of the Axon , 2006, The Journal of Neuroscience.

[20]  D. Luckenbaugh,et al.  The effects of chronic treatment with mood stabilizers on the rat hippocampal post‐synaptic density proteome , 2011, Journal of neurochemistry.

[21]  D J Anderson,et al.  The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes , 1995, Science.

[22]  Francis S Collins,et al.  A HapMap harvest of insights into the genetics of common disease. , 2008, The Journal of clinical investigation.

[23]  M. Tsuang,et al.  Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder. , 2011, Journal of affective disorders.

[24]  Panos Roussos,et al.  The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males , 2011, Bipolar disorders.

[25]  V. Bennett,et al.  AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. , 1995, The Journal of biological chemistry.

[26]  Manuel A. R. Ferreira,et al.  Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4 , 2011, Nature Genetics.

[27]  A. Jackowski,et al.  Is cerebellar volume related to bipolar disorder? , 2011, Journal of affective disorders.

[28]  S. Cichon,et al.  A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder , 2008, Molecular Psychiatry.

[29]  V. Bennett,et al.  Defects in ankyrin-based cellular pathways in metazoan physiology. , 2005, Frontiers in bioscience : a journal and virtual library.

[30]  Vann Bennett,et al.  AnkyrinG Is Required for Clustering of Voltage-gated Na Channels at Axon Initial Segments and for Normal Action Potential Firing , 1998, The Journal of cell biology.

[31]  C. Stefanis,et al.  Bipolar disorder ANK3 risk variant effect on sustained attention is replicated in a large healthy population , 2012, Psychiatric genetics.

[32]  A. Baines,et al.  Ankyrin-G in skeletal muscle: tissue-specific alternative splicing contributes to the complexity of the sarcolemmal cytoskeleton. , 2005, Experimental cell research.

[33]  R. Yolken,et al.  The Stanley Foundation brain collection and Neuropathology Consortium , 2000, Schizophrenia Research.

[34]  L. Siever,et al.  Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. , 2012, Archives of general psychiatry.

[35]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[36]  Cyril Poupon,et al.  Genome-wide supported risk variant for bipolar disorder alters anatomical connectivity in the human brain , 2012, NeuroImage.

[37]  S. Cichon,et al.  Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder , 2008, Molecular Psychiatry.